Capricor Therapeutics, Inc(NASDAQ:CAPR) 
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has comp...
Website: http://www.capricor.com
Founded: 2005
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.88
H 9.26
L 8.33
C 9.06
V 1,943,446
10EMA 9.06
20EMA 9.06
60EMA 9.06
120EMA 9.06
250EMA 9.06